Cargando…

Serial Measurements of N-Terminal Pro-Brain Natriuretic Peptide in Patients with Coronary Heart Disease

OBJECTIVE: To assess the prognostic value of 12-months N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) levels on adverse cardiovascular events in patients with stable coronary heart disease. METHODS: NT-proBNP concentrations were measured at baseline and at 12-months follow-up in participants o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dallmeier, Dhayana, Pencina, Michael J., Rajman, Iris, Koenig, Wolfgang, Rothenbacher, Dietrich, Brenner, Hermann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309398/ https://www.ncbi.nlm.nih.gov/pubmed/25629613 http://dx.doi.org/10.1371/journal.pone.0117143

Ejemplares similares

N‐terminal pro brain natriuretic peptide reference values in community‐dwelling older adults
por: Braisch, Ulrike, et al.
Publicado: (2022)

Repeated Measurements of Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Assess Long-Term Mortality Risk in Subjects with Osteoarthritis
por: Rehm, Martin, et al.
Publicado: (2021)

Repeat Measurements of High Sensitivity Troponins for the Prediction of Recurrent Cardiovascular Events in Patients With Established Coronary Heart Disease: An Analysis From the KAROLA Study
por: Jansen, Henning, et al.
Publicado: (2019)

Cytochrome P450 2C19*2 polymorphism in patients with stable coronary heart disease and risk for secondary cardiovascular disease events: results of a long-term follow-up study in routine clinical care
por: Rothenbacher, Dietrich, et al.
Publicado: (2013)

Objectively Measured Walking Duration and Sedentary Behaviour and Four-Year Mortality in Older People
por: Klenk, Jochen, et al.
Publicado: (2016)

Prognostic Value of Serial N‐Terminal Pro‐B‐Type Natriuretic Peptide Measurements in Adults With Congenital Heart Disease
por: Baggen, Vivan J. M., et al.
Publicado: (2018)

N-terminal pro brain natriuretic peptide in coronary artery disease
por: Tin, Sim Sai, et al.
Publicado: (2015)

Reply to: N-terminal pro brain natriuretic peptide in coronary artery disease
por: Radwan, Hanan, et al.
Publicado: (2015)

Point of care with serial N-terminal pro-B-type natriuretic peptide (NT-proBNP) for heart failure in patients with acute decompensation. An invited commentary
por: Sergi, Consolato M.
Publicado: (2022)

Relationship between Inflammatory Cytokines and Uric Acid Levels with Adverse Cardiovascular Outcomes in Patients with Stable Coronary Heart Disease
por: Rothenbacher, Dietrich, et al.
Publicado: (2012)

Association of lung function with overall mortality is independent of inflammatory, cardiac, and functional biomarkers in older adults: the ActiFE-study
por: Weinmayr, Gudrun, et al.
Publicado: (2020)

Serial Evaluation of Abdominal Fluid and Serum Amino‐terminal pro‐C‐type Natriuretic Peptide in Dogs with Septic Peritonitis
por: Guieu, L.V.S., et al.
Publicado: (2015)

Amino-terminal pro-brain natriuretic peptide in children with latent rheumatic heart disease
por: Zachariah, Justin P, et al.
Publicado: (2016)

Effects of glutamine and valsartan on the brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide of patients with chronic heart failure
por: Shao, Mingliang, et al.
Publicado: (2015)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

Type II Secretory Phospholipase A(2) and Prognosis in Patients with Stable Coronary Heart Disease: Mendelian Randomization Study
por: Breitling, Lutz P., et al.
Publicado: (2011)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)

Prognostic value of long-term trajectories of depression for incident diabetes mellitus in patients with stable coronary heart disease
por: Peter, Raphael S., et al.
Publicado: (2021)

Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure
por: KANNO, Nobuyuki, et al.
Publicado: (2015)

N‐Terminal Pro Brain, N‐Terminal Pro Atrial Natriuretic Peptides, and Dynamic Cerebral Autoregulation
por: Mahinrad, Simin, et al.
Publicado: (2020)

Relationship of atrial fibrillation and N terminal pro brain natriuretic peptide in heart failure patients
por: Nasab Mehrabi, Entezar, et al.
Publicado: (2023)

Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction
por: Cui, Kun, et al.
Publicado: (2018)

Clinical correlation between N-terminal pro-b-type natriuretic peptide and angiographic coronary atherosclerosis
por: Ribeiro, Demóstenes G. L., et al.
Publicado: (2014)

Prognostic value of N-terminal Pro–B-Type natriuretic peptide in patients with intermediate coronary lesions
por: Song, Chenxi, et al.
Publicado: (2022)

Correlation between B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide in patients presenting to an emergency department with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2005)

Multi-state models of transitions in depression and anxiety symptom severity and cardiovascular events in patients with coronary heart disease
por: Meyer, Michelle L., et al.
Publicado: (2019)

NH(2)-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes
por: Lazo, Mariana, et al.
Publicado: (2013)

N-Terminal Pro–B-Type Natriuretic Peptide and Incident CKD
por: Sasaki, Takaya, et al.
Publicado: (2021)

N-terminal pro-brain natriuretic peptide and coronary collateral formation in patients undergoing primary percutaneous coronary intervention
por: Park, Bo Eun, et al.
Publicado: (2021)

Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide
por: Liu, Pang-Yen, et al.
Publicado: (2023)

Correlation Between Levels of N-terminal Pro-B-Type Natriuretic Peptide and Degrees of Heart Failure
por: Song, Bong Geun, et al.
Publicado: (2005)

Determination and stability of N-terminal pro-brain natriuretic peptide in saliva samples for monitoring heart failure
por: Bellagambi, Francesca G., et al.
Publicado: (2021)

Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease
por: Rothenbacher, Dietrich, et al.
Publicado: (2005)

N-terminal pro-brain natriuretic peptide as a biomarker for predicting coronary artery lesion of Kawasaki disease
por: Zheng, Xiaolan, et al.
Publicado: (2020)

Parathormone levels add prognostic ability to N‐terminal pro‐brain natriuretic peptide in stable coronary patients
por: Gutiérrez‐Landaluce, Carlos, et al.
Publicado: (2021)

Relationship between serum N-terminal Pro Brain Natriuretic Peptide (NT-Pro BNP) level and the severity of coronary artery involvements
por: Shahabi, Venous, et al.
Publicado: (2011)

The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology
por: Kimmenade, Van, et al.
Publicado: (2007)

N‐Terminal Pro‐C‐Natriuretic Peptide and Cytokine Kinetics in Dogs with Endotoxemia
por: Floras, A.N.K., et al.
Publicado: (2014)

Levels of N-terminal pro-brain natriuretic peptide in brain injury patients
por: Tsentsiper, L, et al.
Publicado: (2015)

N-terminal Pro-B-Type Natriuretic Peptide and Malnutrition in Patients on Hemodialysis
por: Ducros, Jacques, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jvbdiophb9qpggohdfn4icchv5